17-Hydroxyprogesterone (17-OHP): A Clinical Guide

What Is 17-Hydroxyprogesterone?

If your clinician has ordered a 17-hydroxyprogesterone test, this page will help you understand what it measures and why it matters. 17-Hydroxyprogesterone, often shortened to 17-OHP, is a steroid hormone made mainly by the adrenal glands, and in smaller amounts by the ovaries and testes. It is a middle step in the pathway your body uses to make cortisol (the main stress hormone) and adrenal androgens. Because it sits at a key point in that pathway, the amount of 17-OHP in your blood can show how well certain enzymes along the way are working.

The main reason to measure 17-OHP is to screen for and help diagnose congenital adrenal hyperplasia (CAH), a group of inherited disorders of cortisol production. The most common form comes from a shortage of the enzyme 21-hydroxylase. When this enzyme is missing or reduced, 17-OHP builds up because it cannot move further down the pathway. That makes it a sensitive marker for the condition.

Why This Test Is Ordered

A clinician may order a 17-OHP test in several situations, including:

• Newborn screening: In the United States, 17-OHP is part of the standard newborn screening panel to catch classic CAH early, before a life-threatening adrenal crisis can occur.
• Evaluating ambiguous genitalia or signs of early or atypical puberty in children.
• Investigating adult symptoms such as excess facial or body hair (hirsutism), acne, irregular menstrual cycles, or unexplained infertility, where non-classic (late-onset) CAH is one possibility being considered.
• Telling CAH apart from other causes of high androgens, such as polycystic ovary syndrome (PCOS), which can cause overlapping symptoms.

How the Test Is Performed

17-OHP is measured from a simple blood sample. Timing matters. Levels follow a daily rhythm and are usually highest in the early morning, so samples are commonly drawn in the morning. In menstruating women, the result is best read in the early follicular phase of the cycle, because 17-OHP normally rises after ovulation. If an early morning level is borderline or mildly raised, a clinician may order an ACTH (cosyntropin) stimulation test, which measures how much 17-OHP rises after a dose of synthetic ACTH. This stimulated value helps confirm or rule out non-classic CAH.

Understanding Your Results

Reference ranges for 17-OHP vary meaningfully between laboratories and depend on the assay method used, as well as on age, sex, and menstrual phase. The numbers below are general guides only. Always read your result against the range printed on your own lab report.

• Adults (early-morning, basal): commonly less than about 200 ng/dL, with values in women varying across the menstrual cycle.
• Newborns: have their own age-specific cutoffs, and premature or stressed infants can show briefly higher levels.

Because these ranges are assay-dependent, a value that looks high on one lab’s scale may fall within normal limits on another. Results should always be reviewed alongside your symptoms and other hormone tests.

What High Levels May Mean

An elevated 17-OHP most often points toward congenital adrenal hyperplasia, either the classic form (usually found in infancy with markedly high levels) or the non-classic form (milder elevations that show up later in life). Mild or moderate elevations are not automatically a diagnosis and often need an ACTH stimulation test to clarify them. Less commonly, certain adrenal or ovarian tumors can raise 17-OHP.

What Low or Normal Levels May Mean

A normal or low 17-OHP makes CAH unlikely and may steer the evaluation of androgen-related symptoms toward other causes, such as PCOS. A normal result does not rule out every condition, which is why this test is read in context rather than on its own.

How 17-OHP Fits Into a Broader Workup

17-OHP is rarely read alone. Depending on the clinical picture, a clinician may also check cortisol, ACTH, testosterone, DHEA-S, and other reproductive hormones to build a complete picture of adrenal and gonadal function. Looking at these together helps separate inherited enzyme disorders from more common hormonal conditions and guides the right treatment.

At ENNU Life in Louisville, Kentucky, hormone and metabolic markers like 17-OHP can be considered as part of a thorough, individualized evaluation that connects your lab data to your symptoms and goals.

Take the Next Step

A single biomarker is most useful when it is part of a complete look at your hormonal and metabolic health. A structured assessment can help identify which tests are most relevant for you and what your results may mean.

Start your ENNU Life Health Assessment

Educational only, not medical advice; consult a licensed clinician. Reference ranges are assay-dependent and vary by laboratory, age, sex, and menstrual phase. Do not start, stop, or change any treatment based on this information without guidance from a licensed healthcare professional.